These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 8431727

  • 21. Schizophrenia, drug therapy, and monitoring.
    Bradford DW, Stroup TS.
    N Engl J Med; 2004 Jan 22; 350(4):415-6. PubMed ID: 14736938
    [No Abstract] [Full Text] [Related]

  • 22. Human leukocyte antigen typing, response to neuroleptics, and clozapine-induced agranulocytosis in jewish Israeli schizophrenic patients.
    Meged S, Stein D, Sitrota P, Melamed Y, Elizur A, Shmuelian I, Gazit E.
    Int Clin Psychopharmacol; 1999 Sep 22; 14(5):305-12. PubMed ID: 10529073
    [Abstract] [Full Text] [Related]

  • 23. Clozapine-associated agranulocytosis: risk and aetiology.
    Krupp P, Barnes P.
    Br J Psychiatry Suppl; 1992 May 22; (17):38-40. PubMed ID: 1418887
    [Abstract] [Full Text] [Related]

  • 24. Clozapine: is another view valid?
    Meltzer HY.
    Am J Psychiatry; 1995 Jun 22; 152(6):821-5. PubMed ID: 7755109
    [No Abstract] [Full Text] [Related]

  • 25. Clozapine: a novel antipsychotic.
    Buch DL.
    Am Fam Physician; 1992 Feb 22; 45(2):795-9. PubMed ID: 1739062
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Atypical granulocytopenia in clozapine treatment].
    Hohl U, Hoffmann-Richter U.
    Psychiatr Prax; 1993 Nov 22; 20(6):232-3. PubMed ID: 8310097
    [No Abstract] [Full Text] [Related]

  • 29. Clozapine: an appraisal of its pharmacoeconomic benefits in the treatment of schizophrenia.
    Fitton A, Benfield P.
    Pharmacoeconomics; 1993 Aug 22; 4(2):131-56. PubMed ID: 10146973
    [Abstract] [Full Text] [Related]

  • 30. [Clozapine; an exceptional re-introduction].
    Offerhaus L.
    Ned Tijdschr Geneeskd; 1991 May 25; 135(21):925-7. PubMed ID: 2052107
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Patient knowledge regarding Clozapine-induced agranulocytosis].
    Haberfellner EM, Rittmannsberger H.
    Psychiatr Prax; 2006 May 25; 33(4):194-6. PubMed ID: 16680627
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Clozapine alone versus clozapine and risperidone for refractory schizophrenia.
    Gerson SL.
    N Engl J Med; 2006 Apr 27; 354(17):1846-8; author reply 1846-8. PubMed ID: 16642587
    [No Abstract] [Full Text] [Related]

  • 35. Predictors of clozapine response in schizophrenia.
    Pickar D, Owen RR, Litman RE, Hsiao JK, Su TP.
    J Clin Psychiatry; 1994 Sep 27; 55 Suppl B():129-32. PubMed ID: 7525541
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Add-on filgrastim during clozapine rechallenge in patients with a history of clozapine-related granulocytopenia/agranulocytosis.
    Joffe G, Eskelinen S, Sailas E.
    Am J Psychiatry; 2009 Feb 27; 166(2):236. PubMed ID: 19188296
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.